Report: PET Utilization For Patient Management

Myocardial perfusion imaging (MPI) with positron emission tomography (PET) has been a valuable non-invasive imaging tool used to identify and quantify risk, and to guide therapy in patients with known or suspected coronary artery disease. To better understand the benefits of PET MPI for patient management, MedAxiom interviewed four cardiovascular organizations that added PET MPI as a non-invasive testing option at their facility in the last decade. All of these organizations have found PET MPI to be an integral part of their cardiac imaging programs. A review of program demographics, payer landscape, PET MPI use cases, and key drivers for PET MPI program growth provide valuable insights.

ACCESS THIS REPORT

LEARN MORE ABOUT IONETIX

Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.